| Oct 10 |
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
|
| Aug 13 |
Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript
|
| Aug 13 |
Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 13 |
Mersana Therapeutics GAAP EPS of -$0.20 misses by $0.03, revenue of $2.3M misses by $6.42M
|
| Aug 13 |
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
|
| Aug 12 |
Mersana Therapeutics Q2 2024 Earnings Preview
|
| Aug 1 |
Mersana Therapeutics (NASDAQ:MRSN) shareholders have endured a 83% loss from investing in the stock three years ago
|
